APA (7th ed.) Citation

Y, H., H, W., L, L., Q, L., C, Q., Y, M., . . . X, G. (2026). Preclinical biodistribution and safety evaluation of human iPSC-derived dopaminergic neural progenitor cells for Parkinson's disease. Frontiers in cell and developmental biology, 13, 1701748. https://doi.org/10.3389/fcell.2025.1701748

Chicago Style (17th ed.) Citation

Y, Huang, et al. "Preclinical Biodistribution and Safety Evaluation of Human IPSC-derived Dopaminergic Neural Progenitor Cells for Parkinson's Disease." Frontiers in Cell and Developmental Biology 13 (2026): 1701748. https://doi.org/10.3389/fcell.2025.1701748.

MLA (9th ed.) Citation

Y, Huang, et al. "Preclinical Biodistribution and Safety Evaluation of Human IPSC-derived Dopaminergic Neural Progenitor Cells for Parkinson's Disease." Frontiers in Cell and Developmental Biology, vol. 13, 2026, p. 1701748, https://doi.org/10.3389/fcell.2025.1701748.